Persistent babesiosis in a stem cell transplant recipient

Leukemia Research

Volumn 35, Issue 6, 2011, Pages

  Lubin, Andrew S ^a,b   Snydman, David R ^a   Miller, Kenneth B ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b Winchester Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE; ATOVAQUONE PLUS PROGUANIL; AZITHROMYCIN; CLINDAMYCIN; IMATINIB; IMMUNOGLOBULIN; LACTATE DEHYDROGENASE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; QUININE; RITUXIMAB;

ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; BABESIA; BABESIOSIS; BLOOD SMEAR; BLOOD TRANSFUSION; BONE MARROW BIOPSY; CASE REPORT; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; DISEASE EXACERBATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG TREATMENT FAILURE; FATIGUE; FEVER; HEARING IMPAIRMENT; HEMOLYTIC ANEMIA; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LETTER; MALE; MOUTH MUCOSA; PARASITEMIA; PRIORITY JOURNAL; SKIN;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMALARIALS; ATOVAQUONE; AZITHROMYCIN; BABESIA; BABESIOSIS; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; HUMANS; IMMUNOCOMPROMISED HOST; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; MIDDLE AGED; PARASITEMIA; STEM CELL TRANSPLANTATION;

EID: 79955579195     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2010.11.029     Document Type: Letter

References (10)

1. Vennier E., Gewurz B.E., Krause P.J. Human babesiosis. Infect Dis Clin North Am 2008, 22:469-488.
2. Wormser G.P., Dattwyler R.J., Shapiro E.D., et al. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006, 43:1089-1134.
3. Krause P.J., Lepore T., Sikand V.K., et al. Atovaquone and azithromycin for the treatment of babesiosis. N Engl J Med 2000, 343:1454-1458.
4. Krause P.J., Gewurz B.E., Hill D., et al. Persistent and relapsing babesiosis in immunocompromised patients. Clin Infect Dis 2008, 46:370-376.
5. Clark I.A., Budd A.C., Hsue G., et al. Absence of erythrocyte sequestration in a case of babesiosis in a splenectomized human patient. Malar J 2006, 5:69.
6. Wormser G.P., Prasad A., Neuhaus E., et al. Emergence of resistance to azithromycin-atovaquone in immunocompromised patients with Babesia microti infection. Clin Infect Dis 2010, 50:381-386.
7. Clawson M.L., Paciorkowski N., Rajan T.V., et al. Cellular immunity, but not gamma interferon, is essential for resolution of Babesia microti infection in BALB/c mice. Infect Immun 2002, 70:5304-5306.
8. Cirino C.M., Leitman S.F., Palmore T.N., et al. Transfusion-associated babesiosis with an atypical time course after nonmyeloablative transplantation for sickle cell disease. Ann Intern Med 2008, 148:794-795.
9. Tonnetti L., Eder A.F., Kennedy J., et al. Transfusion-transmitted Babesia microti identified through hemovigilance. Transfusion 2009, 49:2557-2563.
10. Vanier E., Krause P.J. Update on babesiosis. Interdiscip Perspect Infect Dis 2009, 2009:984568. Epub 2009 Aug 27.